| BE0058-25MG
| InVivoMAb anti-mouse TNF?
| 25 mg
| BioXCell
| in vivo TNF? neutralization, in vitro TNF? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0063-25MG
| InVivoMAb anti-mouse GITR
| 25 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0003-1-50MG
| InVivoMAb anti-mouse CD4
| 50 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry, Wes
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0069-100MG
| InVivoMAb anti-mouse 2C TCR
| 100 mg
| BioXCell
| Immunofluorescence, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0051-25MG
| InVivoMAb anti-mouse IL-12 p40
| 25 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0043-1-5MG
| InVivoMAb anti-mouse IL-2
| 5 mg
| BioXCell
| in vivo IL-2 neutralization, in vivo IL-2 receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0086-5MG
| InVivoMAb mouse IgG2b isotype control, unknown specificity
| 5 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0071-25MG
| InVivoMAb anti-mouse/human VLA-4 (CD49d)
| 25 mg
| BioXCell
| in vivo VLA-4 neutralization, in vitro VLA-4 neutr
|
| Rat
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0063-100MG
| InVivoMAb anti-mouse GITR
| 100 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0002-25MG
| InVivoMAb anti-mouse CD3
| 25 mg
| BioXCell
| in vitro T cell stimulation/activation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0047-5MG
| InVivoMAb anti-mouse IL-6R
| 5 mg
| BioXCell
| in vivo blocking of IL-6/IL-6R signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0059-25MG
| InVivoMAb anti-mouse ICOS
| 25 mg
| BioXCell
| in vivo blocking of ICOS/ICOSL signaling, Flow cyt
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0001-1-100MG
| InVivoMAb anti-mouse CD3?
| 100 mg
| BioXCell
| in vivo T cell depletion, in vitro T cell stimulat
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0004-1-50MG
| InVivoMAb anti-mouse CD8?
| 50 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0020-2-50MG
| InVivoMAb anti-human CD54 (ICAM-1)
| 50 mg
| BioXCell
| in vitro T cell stimulation/activation, Immunofluo
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0083-100MG
| InVivoMAb mouse IgG1 isotype control, unknown specificity
| 100 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0061-50MG
| InVivoMAb anti-mouse CD8?
| 50 mg
| BioXCell
| in vivo CD8+ T cell depletion, Western blot
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0002-1MG
| InVivoMAb anti-mouse CD3
| 1 mg
| BioXCell
| in vitro T cell stimulation/activation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0063-50MG
| InVivoMAb anti-mouse GITR
| 50 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0032-1MG
| InVivoMAb anti-mouse CTLA-4 (CD152)
| 1 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0001-2-100MG
| InVivoMAb anti-human CD3
| 100 mg
| BioXCell
| in vitro T cell stimulation/activation, in vivo T
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0011-100MG
| InVivoMAb anti-mouse CD22
| 100 mg
| BioXCell
| in vivo B cell depletion in combination with anti-
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0005-50MG
| InVivoMAb anti-human LFA-1? (CD11a)
| 50 mg
| BioXCell
| in vitro LFA-1 neutralization
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0069-25MG
| InVivoMAb anti-mouse 2C TCR
| 25 mg
| BioXCell
| Immunofluorescence, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0017-1-25MG
| InVivoMAb anti-mouse CD40L (CD154)
| 25 mg
| BioXCell
| in vivo blocking of CD40/CD40L signaling, in vitro
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0049-100MG
| InVivoMAb anti-mouse IL-10
| 100 mg
| BioXCell
| in vivo IL-10 neutralization, in vitro IL-10 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0062-1MG
| InVivoMAb anti-mouse/human Integrin ?7
| 1 mg
| BioXCell
| in vivo blocking of integrin ?7, Immunoprecipitati
|
| Rat
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0015-5-100MG
| InVivoMAb anti-mouse CD28
| 100 mg
| BioXCell
| in vitro T cell stimulation/activation
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0005-1-5MG
| InVivoMAb anti-mouse LFA-1? (CD11a)
| 5 mg
| BioXCell
| in vivo LFA-1 neutralization
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0069-1MG
| InVivoMAb anti-mouse 2C TCR
| 1 mg
| BioXCell
| Immunofluorescence, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0075-25MG
| InVivoMAb anti-mouse Ly6G/Ly6C (Gr-1)
| 25 mg
| BioXCell
| in vivo depletion of Gr-1+ myeloid cells, Flow cyt
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0043-1MG
| InVivoMAb anti-mouse IL-2
| 1 mg
| BioXCell
| in vivo IL-2 neutralization, in vivo IL-2 receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0085-100MG
| InVivoMAb mouse IgG2a isotype control, unknown specificity
| 100 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0003-1-25MG
| InVivoMAb anti-mouse CD4
| 25 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry, Wes
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0006-100MG
| InVivoMAb anti-mouse LFA-1? (CD11a)
| 100 mg
| BioXCell
| in vivo LFA-1 neutralization, Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0060-25MG
| InVivoMAb anti-mouse VEGFR-2
| 25 mg
| BioXCell
| in vivo blocking of VEGF/VEGFR-2 signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0071-5MG
| InVivoMAb anti-mouse/human VLA-4 (CD49d)
| 5 mg
| BioXCell
| in vivo VLA-4 neutralization, in vitro VLA-4 neutr
|
| Rat
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0067-25MG
| InVivoMAb anti-mouse B220
| 25 mg
| BioXCell
| in vivo B cell depletion, in vitro B cell negative
|
|
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0077-100MG
| InVivoMAb anti-mouse MHC Class I (H-2)
| 100 mg
| BioXCell
| ex vivo blocking of MHC I-dependent interactions,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0048-1MG
| InVivoMAb anti-mouse/human IL-7
| 1 mg
| BioXCell
| in vivo IL-7 neutralization, in vivo IL-7 receptor
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0023-1MG
| InVivoMAb anti-human CD71
| 1 mg
| BioXCell
| Immunohistochemistry (frozen), Immunofluorescence,
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0035-25MG
| InVivoMAb anti-mouse MAdCAM-1
| 25 mg
| BioXCell
| in vivo MAdCAM-1 neutralization, Immunofluorescenc
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0036-5MG
| InVivoMAb anti-mouse NK1.1
| 5 mg
| BioXCell
| in vivo NK cell depletion, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0006-5MG
| InVivoMAb anti-mouse LFA-1? (CD11a)
| 5 mg
| BioXCell
| in vivo LFA-1 neutralization, Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0035-50MG
| InVivoMAb anti-mouse MAdCAM-1
| 50 mg
| BioXCell
| in vivo MAdCAM-1 neutralization, Immunofluorescenc
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0049-25MG
| InVivoMAb anti-mouse IL-10
| 25 mg
| BioXCell
| in vivo IL-10 neutralization, in vitro IL-10 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0019-1-50MG
| InVivoMAb anti-human CD47
| 50 mg
| BioXCell
| in vitro CD47 neutralization, in vivo CD47 neutral
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0042-25MG
| InVivoMAb anti-mouse IL-2
| 25 mg
| BioXCell
| in vivo IL-2 neutralization, in vitro IL-2 neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0040-5MG
| InVivoMAb anti-rat CD28
| 5 mg
| BioXCell
| in vitro T cell stimulation/activation, Flow cytom
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0039-5MG
| InVivoMAb anti-mouse/human CD44
| 5 mg
| BioXCell
| in vivo CD44 neutralization, in vitro CD44 neutral
|
| Rat
| Human, Mouse
| Solicitar Precio
| Solicitar
|